|
MarineTech, based in Japan, Canada, US and India with close links to universities, research institutions, is a partner with two major Japanese global corporations. It has a focus on quality protein from marine sources. Applications include human nutrition as well as marine aquaculture feed.
Human Nutrition
The neglect of quality nutrition as a complement to chemical medicines in infectious diseases control is a significant medical need. In Japan, in the post-war era, quality nutrition played a very important part in diseases control. Similarly, it can be very beneficial around the world in combating infectious diseases in combination with chemical medicines.
On chronic diseases, evidence is mounting that components of nutrition such as omega 3 fatty acids, and certain peptides are vital for lowering LDL cholesterol, for increasing HDL cholesterol, and certain peptides have been shown to lower hypertension -- providing a nutritional solution to the complex web of chronic diseases that are descending on the rest of the world after devastating much of the industrial countries.
Aquaculture Feed
Most of the protein from the oceans in the future will come from aquaculture, as per projections of the UN's Food and Agriculture Organization (FAO). 40 to 60% of tons of fish in processing plants is wasted or unused. That "waste" could be utilized beneficially to produce feed for marine aquacuture. This prevents an environmental catastrophe too by preventing methane, CO2 and other pollutants from being released into the atmosphere as "waste" decays.
Proving Efficacy and Safety Cost-Effectively for Natural Substances
There is growing epidemiological evidence of the value in prevention of natural substances like natural statins, omega 3 fatty acids and peptides, and for their use as adjuvants. However, the traditional clinical trials model is too costly for neutraceutical companies to put substances through to seek FDA and other regulatory approval. MarineTech is working with universities and national agencies to create approved pathways to enable efficacy and safety certification.
|
|
|
